Home / Specialties (page 4)

Specialties

SPECIALTIES

Dialysis Changes the Rules: What Happens When Patients With Diabetes Use Real-Time CGM?

Patient with Type 2 diabetes using real-time CGM while receiving maintenance hemodialysis.

Managing glucose is rarely simple for people with Type 2 diabetes who receive maintenance hemodialysis. Dialysis can change glucose patterns, insulin needs, and the reliability of familiar measures such as A1C. As a result, clinicians may have an incomplete picture when making treatment decisions. New randomized research on CGM use …

Read More »

One Diagnosis, Different Diseases? Researchers Uncover Distinct Types of Gestational Diabetes

Pregnant woman discussing gestational diabetes phenotypes and metabolic differences with a healthcare professional.

Gestational diabetes is usually treated as a single diagnosis, but growing evidence suggests the biology behind it can vary considerably from one patient to another. Researchers studying gestational diabetes phenotypes have identified metabolic patterns involving differences in insulin resistance, insulin secretion, or both. These findings raise an important question: Could …

Read More »

More Dietary Fat, Worse Blood Fats? A Low-Carb Diabetes Trial Challenges the Assumption

Low-carb foods including salmon, avocado, nuts, vegetables, and olive oil beside a glucose meter and heart health chart.

Does eating more fat automatically mean that more harmful fatty acids will circulate in the blood? A new randomized trial suggests the answer may be more complicated. Researchers studying a low-carb diet for type 2 diabetes found that six months of carbohydrate restriction changed circulating fatty acids in potentially favorable …

Read More »

Human vs. Analogue Insulin: Does Newer Really Mean Better for Type 1 Diabetes?

Human insulin and analogue insulin options used in Type 1 diabetes treatment

The choice of human vs analogue insulin is especially important for people with Type 1 diabetes who live where healthcare resources are limited. Analogue insulins are often preferred because their action can be more predictable and flexible. However, human insulin is generally less expensive and may be easier for health …

Read More »

When “Type 2” Isn’t Type 2: Clues to Type 3c Diabetes

Pancreas model, glucose meter, and clinical assessment representing type 3c diabetes diagnosis and pancreatogenic diabetes.

A patient develops diabetes in adulthood, so Type 2 diabetes may seem like the obvious diagnosis. However, what if that patient also has chronic pancreatitis, unexplained weight loss, pancreatic surgery, or symptoms of poor nutrient absorption? Those details can change the clinical picture. Careful evaluation can reveal Type 3c diabetes …

Read More »

One Drug Isn’t Enough: When Should Clinicians Combine Treatments for Painful Diabetic Neuropathy?

Clinician discussing diabetic neuropathy pain treatment and combination therapy options with a patient using an anatomical foot model.

Finding the right diabetic neuropathy pain treatment can be challenging when a well-chosen first medication provides only partial relief. Burning, shooting pain, tingling, and allodynia can continue to disrupt sleep, mobility, mood, and daily function. Fortunately, clinicians do not always have to choose between abandoning a partially effective drug and …

Read More »

Diagnosed Younger: Does Type 1 Onset Shape Later Risk?

Child, teenager, and adult with type 1 diabetes illustrating how age at onset may relate to long-term complication risks.

Does being diagnosed with type 1 diabetes at age 6 carry the same long-term risks as being diagnosed at 16? Researchers have been asking that question for years. Increasingly, evidence suggests that age at type 1 diabetes onset may help explain differences in complication patterns later in life. However, age …

Read More »

After Gestational Diabetes, Could Your Neighborhood Shape Your Future Type 2 Risk?

Mother walking with her baby in a walkable neighborhood, illustrating gestational diabetes prevention and future Type 2 diabetes risk.

Diabetes prevention remains important long after a pregnancy affected by gestational diabetes. For people who have had gestational diabetes, the years after delivery are an important window for lowering the risk of Type 2 diabetes. Yet healthy choices do not happen in a vacuum. Where someone lives may affect whether …

Read More »

Beyond hs-CRP: Could suPAR Reveal Hidden Heart Risk in Type 2 Diabetes?

suPAR biomarker blood test with heart model and glucose meter representing cardiovascular risk in type 2 diabetes

People with type 2 diabetes can face substantial cardiovascular risk even when clinicians address familiar risk factors such as LDL cholesterol, blood pressure, smoking, and blood glucose. Could another blood marker help reveal some of the risk that remains? Emerging research on the suPAR biomarker in diabetes suggests it may …

Read More »